Advertisement

How can Plegridy help treat people with relapsing-remitting MS?

Plegridy, a new interferon product, has received U.S. Food and Drug Administration (FDA) approval as a treatment for relapsing forms of multiple sclerosis (MS). In a clinical trial, Plegridy was shown to significantly reduce important clinical and imaging measures, including slowing the progression of disability and decreasing the number of relapses and brain lesions. Plegridy is given by subcutaneous injection every two weeks. 

Continue Learning about Multiple Sclerosis Treatment

What to Expect from MS Infusion Therapies
What to Expect from MS Infusion Therapies
Several therapies for multiple sclerosis are delivered with an infusion, where a venous catheter is inserted into a vein and medicine is delivered int...
Read More
How is multiple sclerosis (MS) treated?
Dr. Louis RosnerDr. Louis Rosner
First, treatments of multiple sclerosis (MS) don’t stand the test of time. If they were effective, t...
More Answers
What kind of specialists should I see for my multiple sclerosis (MS)?
Multiple Sclerosis FoundationMultiple Sclerosis Foundation
Multiple sclerosis (MS) is a multifactorial disease, meaning that it can create many symptoms. There...
More Answers
Why Should I Avoid Caffeine if I Have Multiple Sclerosis?
Why Should I Avoid Caffeine if I Have Multiple Sclerosis?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.